Skip to Content

111 Results Found

  • Article
  • Open Access
10 Citations
3,025 Views
19 Pages

[18F]Flotaza for Aβ Plaque Diagnostic Imaging: Evaluation in Postmortem Human Alzheimer’s Disease Brain Hippocampus and PET/CT Imaging in 5xFAD Transgenic Mice

  • Yasmin K. Sandhu,
  • Harman S. Bath,
  • Jasmine Shergill,
  • Christopher Liang and ,
  • Amina U. Syed,
  • Allyson Ngo,
  • Fariha Karim,
  • Geidy E. Serrano,
  • Thomas G. Beach and
  • Jogeshwar Mukherjee
  • + 5 authors+ 0 author

The diagnostic value of imaging Aβ plaques in Alzheimer’s disease (AD) has accelerated the development of fluorine-18 labeled radiotracers with a longer half-life for easier translation to clinical use. We have developed [18F]flotaza, whic...

(This article belongs to the Special Issue Breakthroughs in Diagnostic Prediction and Fundamental Therapeutics of Dementia and Movement Disorders)
  • Article
  • Open Access
27 Citations
3,435 Views
18 Pages

Comparison of Monoamine Oxidase-A, Aβ Plaques, Tau, and Translocator Protein Levels in Postmortem Human Alzheimer’s Disease Brain

  • Amina U. Syed,
  • Christopher Liang,
  • Krystal K. Patel,
  • Rommani Mondal and ,
  • Vallabhi M. Kamalia,
  • Taylor R. Moran,
  • Shamiha T. Ahmed and
  • Jogeshwar Mukherjee
  • + 3 authors+ 0 author

Increased monoamine oxidase-A (MAO-A) activity in Alzheimer’s disease (AD) may be detrimental to the point of neurodegeneration. To assess MAO-A activity in AD, we compared four biomarkers, Aβ plaques, tau, translocator protein (TSPO), and...

(This article belongs to the Special Issue Molecular Aspects of the Neurodegenerative Brain Diseases)
  • Article
  • Open Access
4 Citations
2,425 Views
14 Pages

Evaluation of [125I]α-Bungarotoxin Binding to α7 Nicotinic Acetylcholinergic Receptors in Hippocampus–Subiculum of Postmortem Human Alzheimer’s Disease Brain

  • Allyson Ngo,
  • Fariha Karim,
  • Oshini V. Keerthisinghe,
  • Tram B. Danh and ,
  • Christopher Liang and
  • Jogeshwar Mukherjee
  • + 1 author+ 0 author

Background/Objectives: Alzheimer’s disease (AD) severely hinders cognitive function in the hippocampus (HP) and subiculum (SUB), impacting the expression of nicotinic acetylcholine receptors (nAChRs) such as the α7-subtype. To investigate...

  • Article
  • Open Access
10 Citations
9,044 Views
13 Pages

[125I]IPC-Lecanemab: Synthesis and Evaluation of Aβ-Plaque-Binding Antibody and Comparison with Small-Molecule [18F]Flotaza and [125I]IBETA in Postmortem Human Alzheimer’s Disease

  • Christopher Liang,
  • Cayz G. Paclibar,
  • Noresa L. Gonzaga,
  • Stephanie A. Sison and ,
  • Harman S. Bath,
  • Agnes P. Biju and
  • Jogeshwar Mukherjee
  • + 2 authors+ 0 author

8 April 2024

Therapeutic antibodies for reducing Aβ plaque load in Alzheimer’s disease (AD) is currently making rapid progress. The diagnostic imaging of Aβ plaque load in AD has been underway and is now used in clinical studies. Here, we report o...

  • Article
  • Open Access
21 Citations
6,147 Views
15 Pages

Measurement of Aβ Amyloid Plaques and Tau Protein in Postmortem Human Alzheimer’s Disease Brain by Autoradiography Using [18F]Flotaza, [125I]IBETA, [124/125I]IPPI and Immunohistochemistry Analysis Using QuPath

  • Rommani Mondal,
  • Yasmin K. Sandhu,
  • Vallabhi M. Kamalia,
  • Brooke A. Delaney and ,
  • Amina U. Syed,
  • Grace A. H. Nguyen,
  • Taylor R. Moran,
  • Roz R. Limpengco,
  • Christopher Liang and
  • Jogeshwar Mukherjee
  • + 5 authors+ 0 author

High-resolution scans of immunohistochemical (IHC) stains of Alzheimer’s disease (AD) brain slices and radioligand autoradiography both provide information about the distribution of Aβ plaques and Tau, the two common proteinopathies in AD....

(This article belongs to the Special Issue Biomedicines: 10th Anniversary)
  • Article
  • Open Access
6 Citations
3,683 Views
12 Pages

Development of [124/125I]IAZA as a New Proteinopathy Imaging Agent for Alzheimer’s Disease

  • Thrisha T. Reddy,
  • Michael H. Iguban,
  • Lusine L. Melkonyan,
  • Jasmine Shergill and ,
  • Christopher Liang and
  • Jogeshwar Mukherjee
  • + 1 author+ 0 author

15 January 2023

Radioiodinated imaging agents for Aβ amyloid plaque imaging in Alzheimer’s disease (AD) patients have not been actively pursued. Our previous studies employed the “diaza” derivatives [11C]TAZA and [18F]flotaza in order to devel...

(This article belongs to the Section Medicinal Chemistry)
  • Article
  • Open Access
18 Citations
3,490 Views
17 Pages

17 July 2022

Several fluorine-18-labeled PET β-amyloid (Aβ) plaque radiotracers for Alzheimer’s disease (AD) are in clinical use. However, no radioiodinated imaging agent for Aβ plaques has been successfully moved forward for either single-ph...

(This article belongs to the Section Medicinal Chemistry)
  • Article
  • Open Access
9 Citations
3,684 Views
25 Pages

30 January 2024

Alzheimer’s disease (AD) is a progressive neurodegenerative disorder that is characterized by amyloid-beta (Aβ) plaques and tau neurofibrillary tangles (NFT). Modelling aspects of AD is challenging due to its complex multifactorial etiolog...

(This article belongs to the Special Issue Role of Amyloid Protein in Neurological Diseases)
  • Review
  • Open Access
17 Citations
5,483 Views
15 Pages

Switching On/Off Amyloid Plaque Formation in Transgenic Animal Models of Alzheimer’s Disease

  • Sergey A. Kozin,
  • Olga I. Kechko,
  • Alexei A. Adzhubei,
  • Alexander A. Makarov and
  • Vladimir A. Mitkevich

A hallmark of Alzheimer’s disease (AD) are the proteinaceous aggregates formed by the amyloid-beta peptide (Aβ) that is deposited inside the brain as amyloid plaques. The accumulation of aggregated Aβ may initiate or enhance pathologi...

(This article belongs to the Topic Advances in Diagnostics, Brain Delivery Systems and Therapeutics of Neurodegenerative Disease)
  • Review
  • Open Access
88 Citations
11,842 Views
13 Pages

Worldwide, Alzheimer’s disease (AD) is the most common age-related neurodegenerative disease and is characterized by unique pathological hallmarks in the brain, including plaques composed of amyloid β-protein (Aβ) and neurofibrillary...

(This article belongs to the Special Issue Amyloid-β: Structure, Function, and Pathophysiological Significance in Neurodegenerative Diseases)
  • Article
  • Open Access
3 Citations
2,037 Views
18 Pages

Cerebellar Resistance to Amyloid Plaque Deposition and Elevated Microglial ECM Proteoglycan Uptake in 5xFAD Mice

  • Carla Cangalaya,
  • Henning Peter Düsedau,
  • Ildiko Rita Dunay,
  • Alexander Dityatev and
  • Stoyan Stoyanov

19 January 2026

In both Alzheimer’s disease (AD) patients and animal models, senile plaques are generally observed in the cerebral cortex rather than the cerebellum. The mechanisms underlying the regional resistance of the cerebellum to amyloid plaque depositi...

(This article belongs to the Section Cellular Aging)
  • Article
  • Open Access
8 Citations
2,614 Views
21 Pages

Vimentin Fragmentation and Its Role in Amyloid-Beta Plaque Deposition in Alzheimer’s Disease

  • Lan Zhang,
  • Ji Wang,
  • Yalong Yan,
  • Lihong Xiang and ,
  • Xinyue Zhai,
  • Lianmei Cai,
  • Zhuoran Sun,
  • Mingshan Pi,
  • Qi Xiong and
  • Yiyuan Xia
  • + 9 authors+ 4 authors

Intermediate filament protein vimentin (Vim) is a well-established marker for reactive astrocytes and has been closely associated with Alzheimer’s disease (AD). RNA sequencing data reveal elevated expression of Vim in AD brains, with its aggreg...

(This article belongs to the Section Molecular Immunology)
  • Article
  • Open Access
13 Citations
3,363 Views
17 Pages

Molecular Mechanism of Zinc-Dependent Oligomerization of Alzheimer’s Amyloid-β with Taiwan (D7H) Mutation

  • Olga I. Kechko,
  • Alexei A. Adzhubei,
  • Anna P. Tolstova,
  • Maria I. Indeykina and ,
  • Igor A. Popov,
  • Sergey S. Zhokhov,
  • Nikolay V. Gnuchev,
  • Vladimir A. Mitkevich,
  • Alexander A. Makarov and
  • Sergey A. Kozin
  • + 5 authors+ 0 author

Amyloid-β (Aβ) is a peptide formed by 39–43 amino acids, heterogenous by the length of its C-terminus. Aβ constitutes a subnanomolar monomeric component of human biological fluids; however, in sporadic variants of Alzheimer&rsquo...

(This article belongs to the Special Issue New Targets and Approaches for the Treatment of Alzheimer's Disease and Related Disorders)
  • Article
  • Open Access
8 Citations
12,271 Views
20 Pages

There is an urgent need to identify interventions that broadly target aging-related cognitive decline and progression to Alzheimer’s disease (AD). Bottlenose dolphins (Tursiops truncatus) have histologic changes similar to AD in humans, and the...

(This article belongs to the Special Issue Bioactive Lipids: From the Perspective of Cellular and Molecular Mechanisms)
  • Review
  • Open Access
6 Citations
4,056 Views
16 Pages

Human brain aging is characterized by the production and deposition of β-amyloid (Aβ) in the form of senile plaques and cerebral amyloid angiopathy and the intracellular accumulation of hyper-phosphorylated tau (Hp-tau) to form neurofibrill...

(This article belongs to the Section Molecular Neurobiology)
  • Article
  • Open Access
90 Citations
17,937 Views
17 Pages

Donanemab for Alzheimer’s Disease: A Systematic Review of Clinical Trials

  • Areeba Rashad,
  • Atta Rasool,
  • Muhammad Shaheryar,
  • Azza Sarfraz and ,
  • Zouina Sarfraz,
  • Karla Robles-Velasco and
  • Ivan Cherrez-Ojeda
  • + 2 authors+ 0 author

22 December 2022

Amyloid-β (Aβ) plaques and aggregated tau are two core mechanisms that contribute to the clinical deterioration of Alzheimer’s disease (AD). Recently, targeted-Aβ plaque reduction immunotherapies have been explored for their effi...

(This article belongs to the Section Chronic Care)
  • Article
  • Open Access
14 Citations
5,159 Views
15 Pages

The Dynamics of β-Amyloid Proteoforms Accumulation in the Brain of a 5xFAD Mouse Model of Alzheimer’s Disease

  • Anna E. Bugrova,
  • Polina A. Strelnikova,
  • Maria I. Indeykina,
  • Alexey S. Kononikhin and ,
  • Natalia V. Zakharova,
  • Alexander G. Brzhozovskiy,
  • Evgeny P. Barykin,
  • Stanislav I. Pekov,
  • Maria S. Gavrish and
  • Evgeny N. Nikolaev
  • + 12 authors+ 7 authors

Alzheimer’s disease (AD) is the leading cause of dementia among the elderly. Neuropathologically, AD is characterized by the deposition of a 39- to 42-amino acid long β-amyloid (Aβ) peptide in the form of senile plaques. Several post-...

(This article belongs to the Special Issue Molecular Pathogenesis of Neurodegenerative Diseases Targeting Diagnosis and Treatment)
  • Article
  • Open Access
4 Citations
3,136 Views
14 Pages

Altering Brain Amyloidosis by Intra-Lingual and Extra-Nasal Exposure of Aβ Aggregates

  • Nazaret Gamez,
  • Javiera Bravo-Alegria,
  • Yumeng Huang,
  • Nelson Perez-Urrutia and ,
  • Deepa Dongarwar,
  • Claudio Soto and
  • Rodrigo Morales
  • + 2 authors+ 0 author

31 October 2022

Extensive experimental and human-derived evidence suggest that misfolded Aβ particles spread similarly to infectious prions. Moreover, peripheral administration of Aβ seeds accelerates brain amyloidosis in both susceptible experimental anim...

(This article belongs to the Special Issue Alzheimer's Disease: Molecular Mechanisms and Novel Treatment Strategies)
  • Article
  • Open Access
12 Citations
4,572 Views
16 Pages

Neurogenesis Is Increased in Human Neural Stem Cells by Aβ40 Peptide

  • Adela Bernabeu-Zornoza,
  • Raquel Coronel,
  • Charlotte Palmer,
  • Alberto Martín and ,
  • Victoria López-Alonso and
  • Isabel Liste
  • + 1 author+ 0 author

Amyloid-β 40 peptides [Aβ1-40 (Aβ40)] are present within amyloid plaques in the brains of patients with Alzheimer’s disease (AD). Even though Aβ peptides are considered neurotoxic, they can mediate many biological processes,...

(This article belongs to the Special Issue Advances in Stem Cell Research for Future Therapies and In Vitro Disease Modelling)
  • Article
  • Open Access
17 Citations
5,560 Views
21 Pages

A Novel Peroxidase Mimics and Ameliorates Alzheimer’s Disease-Related Pathology and Cognitive Decline in Mice

  • Jia Xu,
  • Kai Wang,
  • Ye Yuan,
  • Hui Li and ,
  • Ruining Zhang,
  • Shuwen Guan and
  • Liping Wang
  • + 2 authors+ 0 author

24 October 2018

Alzheimer’s disease (AD) is the most common neurodegenerative disorder in the elderly, which is characterized by the accumulation of amyloid β (Aβ) plaques, oxidative stress, and neuronal loss. Therefore, clearing Aβ aggregates a...

(This article belongs to the Section Molecular Pathology, Diagnostics, and Therapeutics)
  • Article
  • Open Access
23 Citations
4,713 Views
18 Pages

ORAI2 Down-Regulation Potentiates SOCE and Decreases Aβ42 Accumulation in Human Neuroglioma Cells

  • Elena Scremin,
  • Mario Agostini,
  • Alessandro Leparulo,
  • Tullio Pozzan and ,
  • Elisa Greotti and
  • Cristina Fasolato
  • + 1 author+ 0 author

Senile plaques, the hallmarks of Alzheimer’s Disease (AD), are generated by the deposition of amyloid-beta (Aβ), the proteolytic product of amyloid precursor protein (APP), by β and γ-secretase. A large body of evidence points t...

(This article belongs to the Special Issue Cell Signaling in Neurodegeneration)
  • Article
  • Open Access
11 Citations
3,367 Views
18 Pages

Oligomeric and Fibrillar Species of Aβ42 Diversely Affect Human Neural Stem Cells

  • Adela Bernabeu-Zornoza,
  • Raquel Coronel,
  • Charlotte Palmer,
  • Victoria López-Alonso and
  • Isabel Liste

2 September 2021

Amyloid-β 42 peptide (Aβ1-42 (Aβ42)) is well-known for its involvement in the development of Alzheimer’s disease (AD). Aβ42 accumulates and aggregates in fibers that precipitate in the form of plaques in the brain causing toxicity; however, like othe...

(This article belongs to the Special Issue Advances in Stem Cell Research for Future Therapies and In Vitro Disease Modelling)
  • Review
  • Open Access
65 Citations
10,518 Views
31 Pages

30 January 2018

Intracellular synthesis, folding, trafficking and degradation of proteins are controlled and integrated by proteostasis. The frequency of protein misfolding disorders in the human population, e.g., in Alzheimer’s disease (AD), is increasing due to th...

(This article belongs to the Special Issue Peptide Therapeutics)
  • Article
  • Open Access
70 Citations
10,246 Views
18 Pages

Amyloid-Beta Peptides Trigger Aggregation of Alpha-Synuclein In Vitro

  • Janett Köppen,
  • Anja Schulze,
  • Lisa Machner,
  • Michael Wermann and ,
  • Rico Eichentopf,
  • Max Guthardt,
  • Angelika Hähnel,
  • Jessica Klehm,
  • Marie-Christin Kriegeskorte and
  • Stephan Schilling
  • + 10 authors+ 5 authors

29 January 2020

Alzheimer’s disease (AD) and Parkinson’s disease (PD), including dementia with Lewy bodies (DLB), account for the majority of dementia cases worldwide. Interestingly, a significant number of patients have clinical and neuropathological fe...

(This article belongs to the Special Issue Amyloids in Neurodegenerative Diseases)
  • Article
  • Open Access
7 Citations
3,150 Views
26 Pages

23 September 2024

A characteristic feature of Alzheimer’s disease (AD) is the formation of neuronal extracellular senile plaques composed of aggregates of fibrillar amyloid β (Aβ) peptides, with the Aβ1-42 peptide being the most abundant species....

(This article belongs to the Section Cellular Aging)
  • Article
  • Open Access
849 Views
18 Pages

Low-Intensity Focused Ultrasound Alters Alzheimer’s Disease Pathology, In Vivo, as a Function of Ultrasound Dose and Age

  • Alissa Phutirat,
  • Kahte A. Culevski,
  • Hannah Mach,
  • Jamie Kwon and ,
  • Henry Tan,
  • Gabe Koh,
  • Caren Marzban and
  • Pierre D. Mourad
  • + 3 authors+ 0 author

Background/Objectives: Alzheimer’s Disease (AD) and vascular dementia contribute up to ~75% of dementia cases, as determined via autopsy. AD arises in part due to the buildup of aberrant proteins (amyloid beta (Aβ) and Tau); vascular demen...

(This article belongs to the Special Issue Noninvasive Neuromodulation Applications in Research and Clinics—2nd Edition)
  • Communication
  • Open Access
9 Citations
4,158 Views
8 Pages

Distinguishing Amyloid β-Protein in a Mouse Model of Alzheimer’s Disease by Label-Free Vibrational Imaging

  • Shaowei Li,
  • Ziyi Luo,
  • Renlong Zhang,
  • Hao Xu and ,
  • Ting Zhou,
  • Liwei Liu and
  • Junle Qu
  • + 2 authors+ 0 author

30 September 2021

Due to the increase in the average age of humans, Alzheimer’s disease (AD) has become one of the disorders with the highest incidence worldwide. Abnormal amyloid β protein (Aβ) accumulation is believed to be the most common cause of AD. Therefore, di...

(This article belongs to the Special Issue Optical Sensors for Bio-Sensing, Imaging and Theranostics Applications)
  • Article
  • Open Access
4 Citations
4,034 Views
18 Pages

Amyloid-Beta Peptides Trigger Premature Functional and Gene Expression Alterations in Human-Induced Neurons

  • Ana Raquel Melo de Farias,
  • Alexandre Pelletier,
  • Lukas Cruz Carvalho Iohan,
  • Orthis Saha and ,
  • Amélie Bonnefond,
  • Philippe Amouyel,
  • Fabien Delahaye,
  • Jean-Charles Lambert and
  • Marcos R. Costa
  • + 4 authors+ 0 author

18 September 2023

Alzheimer’s disease (AD) is the most prevalent cause of dementia in the elderly, characterized by the presence of amyloid-beta (Aβ) plaques, neurofibrillary tangles, neuroinflammation, synapse loss and neurodegeneration in the brain. The a...

(This article belongs to the Section Neurobiology and Clinical Neuroscience)
  • Protocol
  • Open Access
9 Citations
9,985 Views
16 Pages

Amyloid plaques found in the brains of Alzheimer’s disease patients primarily consists of amyloid beta 1-42 (Aβ42). Commercially, Aβ42 is synthesized using high-throughput peptide synthesizers resulting in the presence of impurities a...

  • Article
  • Open Access
4 Citations
2,634 Views
20 Pages

17 October 2023

Amyloid β (Aβ) oligomers are the most neurotoxic forms of Aβ, and Aβ(1–42) is the prevalent Aβ peptide found in the amyloid plaques of Alzheimer’s disease patients. Aβ(25–35) is the shortest peptide tha...

(This article belongs to the Special Issue Themed Issue in Honor of Carlos Gutiérrez Merino: Forty Years of Research Excellence in the Field of Membrane Proteins and Bioenergetics)
  • Article
  • Open Access
19 Citations
4,216 Views
14 Pages

10 September 2021

Alzheimer’s disease (AD) is marked by chronic neurodegeneration associated with the occurrence of plaques containing amyloid β (Aβ) proteins in various parts of the human brain. An increase in several Aβ fragments is well documented in patients with...

(This article belongs to the Section Cell Signaling)
  • Article
  • Open Access
4 Citations
2,600 Views
15 Pages

Screening of a Fraction with Higher Amyloid β Aggregation Inhibitory Activity from a Library Containing 210 Mushroom Extracts Using a Microliter-Scale High-Throughput Screening System with Quantum Dot Imaging

  • Gegentuya Huanood,
  • Mahadeva M. M. Swamy,
  • Rina Sasaki,
  • Keiya Shimamori and ,
  • Masahiro Kuragano,
  • Enkhmaa Enkhbat,
  • Yoshiko Suga,
  • Masaki Anetai,
  • Kenji Monde and
  • Kiyotaka Tokuraku
  • + 5 authors+ 0 author

22 November 2024

Alzheimer’s disease (AD) is a highly prevalent neurodegenerative disease hallmarked by amyloid plaques and neurofibrillary tangles. Amyloid plaques are formed by the amyloid β (Aβ) aggregation, so substances that inhibit this aggregat...

(This article belongs to the Special Issue Nanomaterials and Nanotechnology in Food: Applicability, Functionality, and Safety—2nd Edition)
  • Article
  • Open Access
4,551 Views
16 Pages

Novel Monoclonal Antibody Specific toward Amyloid-β Binds to a Unique Epitope within the N-Terminal Region

  • Giavanna Paterno,
  • Brenda D. Moore,
  • Brach M. Bell,
  • Kimberly-Marie M. Gorion and ,
  • Yong Ran,
  • Stefan Prokop,
  • Todd E. Golde and
  • Benoit I. Giasson
  • + 3 authors+ 0 author

9 August 2024

Amyloid-β (Aβ) deposition throughout the neuroaxis is a classical hallmark of several neurodegenerative diseases, most notably Alzheimer’s disease (AD). Aβ peptides of varied length and diverse structural conformations are deposi...

  • Article
  • Open Access
4 Citations
5,033 Views
22 Pages

Selective In Vitro and Ex Vivo Staining of Brain Neurofibrillary Tangles and Amyloid Plaques by Novel Ethylene Ethynylene-Based Optical Sensors

  • Florencia A. Monge,
  • Adeline M. Fanni,
  • Patrick L. Donabedian,
  • Jonathan Hulse and ,
  • Nicole M. Maphis,
  • Shanya Jiang,
  • Tia N. Donaldson,
  • Benjamin J. Clark,
  • David G. Whitten and
  • Eva Y. Chi
  • + 6 authors+ 1 author

18 January 2023

The identification of protein aggregates as biomarkers for neurodegeneration is an area of interest for disease diagnosis and treatment development. In this work, we present novel super luminescent conjugated polyelectrolyte molecules as ex vivo sens...

(This article belongs to the Special Issue Biosensors and Neuroscience)
  • Article
  • Open Access
4 Citations
2,152 Views
11 Pages

Involvement of Endolysosomes and Aurora Kinase A in the Regulation of Amyloid β Protein Levels in Neurons

  • Zahra Afghah,
  • Nabab Khan,
  • Gaurav Datta,
  • Peter W. Halcrow and ,
  • Jonathan D. Geiger and
  • Xuesong Chen
  • + 1 author+ 0 author

Aurora kinase A (AURKA) is a serine/threonine-protein kinase that regulates microtubule organization during neuron migration and neurite formation. Decreased activity of AURKA was found in Alzheimer’s disease (AD) brain samples, but little is k...

(This article belongs to the Section Molecular Neurobiology)
  • Article
  • Open Access
9 Citations
3,357 Views
16 Pages

In Search for Low-Molecular-Weight Ligands of Human Serum Albumin That Affect Its Affinity for Monomeric Amyloid β Peptide

  • Evgenia I. Deryusheva,
  • Marina P. Shevelyova,
  • Victoria A. Rastrygina,
  • Ekaterina L. Nemashkalova and ,
  • Alisa A. Vologzhannikova,
  • Andrey V. Machulin,
  • Alija A. Nazipova,
  • Maria E. Permyakova,
  • Sergei E. Permyakov and
  • Ekaterina A. Litus
  • + 5 authors+ 0 author

An imbalance between production and excretion of amyloid β peptide (Aβ) in the brain tissues of Alzheimer’s disease (AD) patients leads to Aβ accumulation and the formation of noxious Aβ oligomers/plaques. A promising approa...

(This article belongs to the Special Issue Serum Albumin in Health and Disease: From Comparative Biochemistry to Translational Medicine 2.0)
  • Article
  • Open Access
36 Citations
6,130 Views
13 Pages

Conformational Dynamics and Stability of U-Shaped and S-Shaped Amyloid β Assemblies

  • Gianvito Grasso,
  • Martina Rebella,
  • Stefano Muscat,
  • Umberto Morbiducci and ,
  • Jack Tuszynski,
  • Andrea Danani and
  • Marco A. Deriu
  • + 2 authors+ 0 author

14 February 2018

Alzheimer’s disease is the most fatal neurodegenerative disorder characterized by the aggregation and deposition of Amyloid β (Aβ) oligomers in the brain of patients. Two principal variants of Aβ exist in humans: Aβ1–40 and Aβ1–42. The former is the...

(This article belongs to the Special Issue Protein Structural Dynamics)
  • Review
  • Open Access
25 Citations
6,666 Views
21 Pages

Structural Studies Providing Insights into Production and Conformational Behavior of Amyloid-β Peptide Associated with Alzheimer’s Disease Development

  • Anatoly S. Urban,
  • Konstantin V. Pavlov,
  • Anna V. Kamynina,
  • Ivan S. Okhrimenko and ,
  • Alexander S. Arseniev and
  • Eduard V. Bocharov
  • + 1 author+ 0 author

Alzheimer’s disease is the most common type of neurodegenerative disease in the world. Genetic evidence strongly suggests that aberrant generation, aggregation, and/or clearance of neurotoxic amyloid-β peptides (Aβ) triggers the disease. Aβ accumulat...

(This article belongs to the Special Issue Bioactive Peptides and Proteins)
  • Article
  • Open Access
34 Citations
17,753 Views
24 Pages

23 April 2009

Cerebral amyloid angiopathy (CAA) refers to the specific deposition of amyloid fibrils in the leptomeningeal and cerebral blood vessel walls, often causing secondary vascular degenerative changes. Although many kinds of peptides are known to be depos...

(This article belongs to the Special Issue Advances in Molecular Neuropathology)
  • Article
  • Open Access
32 Citations
4,623 Views
23 Pages

17 September 2022

Amyloid aggregation is associated with many neurodegenerative diseases such as Alzheimer’s disease (AD). The current technologies using phototherapy for amyloid inhibition are usually photodynamic approaches based on evidence that reactive oxyg...

(This article belongs to the Special Issue Advance in Neurotoxicity Research from Development to Aging)
  • Communication
  • Open Access
3 Citations
3,145 Views
14 Pages

The Proof-of-Concept of MBA121, a Tacrine–Ferulic Acid Hybrid, for Alzheimer’s Disease Therapy

  • Emelina R. Rodríguez-Ruiz,
  • Raquel Herrero-Labrador,
  • Ana P. Fernández-Fernández,
  • Julia Serrano-Masa and ,
  • José A. Martínez-Montero,
  • Daniel González-Nieto,
  • Mayuri Hana-Vaish,
  • Mohamed Benchekroun,
  • Lhassane Ismaili and
  • Ricardo Martínez-Murillo
  • + 6 authors+ 1 author

Great effort has been devoted to the synthesis of novel multi-target directed tacrine derivatives in the search of new treatments for Alzheimer’s disease (AD). Herein we describe the proof of concept of MBA121, a compound designed as a tacrine&...

(This article belongs to the Special Issue Advances in Alzheimer’s Disease Drug Research and Development)
  • Article
  • Open Access
10 Citations
2,769 Views
16 Pages

19 December 2023

In Alzheimer’s disease, the blood–brain barrier breakdown, blood vessel damage and re-organization are early events. Deposits of the small toxic peptide beta-amyloid (Aβ) cause the formation of extracellular plaques and accumulate in...

(This article belongs to the Collection Feature Papers in Section 'Molecular Medicine')
  • Review
  • Open Access
33 Citations
6,805 Views
28 Pages

Amyloids: The History of Toxicity and Functionality

  • Elmira I. Yakupova,
  • Liya G. Bobyleva,
  • Sergey A. Shumeyko,
  • Ivan M. Vikhlyantsev and
  • Alexander G. Bobylev

Proteins can perform their specific function due to their molecular structure. Partial or complete unfolding of the polypeptide chain may lead to the misfolding and aggregation of proteins in turn, resulting in the formation of different structures s...

(This article belongs to the Special Issue Protein Folding, Aggregation, and Cell Death)
  • Article
  • Open Access
3 Citations
3,402 Views
24 Pages

Functional Relationships between L1CAM, LC3, ATG12, and Aβ

  • Gabriele Loers,
  • Ute Bork and
  • Melitta Schachner

9 October 2024

Abnormal protein accumulations in the brain are linked to aging and the pathogenesis of dementia of various types, including Alzheimer’s disease. These accumulations can be reduced by cell indigenous mechanisms. Among these is autophagy, whereb...

(This article belongs to the Section Molecular Neurobiology)
  • Article
  • Open Access
53 Citations
8,707 Views
11 Pages

N-Alkyl Carbazole Derivatives as New Tools for Alzheimer’s Disease: Preliminary Studies

  • Carmela Saturnino,
  • Domenico Iacopetta,
  • Maria Stefania Sinicropi,
  • Camillo Rosano and ,
  • Anna Caruso,
  • Angelamaria Caporale,
  • Nancy Marra,
  • Barbara Marengo,
  • Maria Adelaide Pronzato and
  • Roberta Ricciarelli
  • + 7 authors+ 2 authors

2 July 2014

Alzheimer’s disease (AD) is a progressive and age-related neurodegenerative disorder affecting brain cells and is the most common form of “dementia”, because of the cognitive detriment which takes place. Neuronal disruption represents its major featu...

(This article belongs to the Section Medicinal Chemistry)
  • Article
  • Open Access
19 Citations
9,640 Views
24 Pages

Multigram Synthesis and in Vivo Efficacy Studies of a Novel Multitarget Anti-Alzheimer’s Compound

  • Irene Sola,
  • Elisabet Viayna,
  • Tània Gómez,
  • Carles Galdeano and ,
  • Matteo Cassina,
  • Pelayo Camps,
  • Margherita Romeo,
  • Luisa Diomede,
  • Mario Salmona and
  • Diego Muñoz-Torrero
  • + 12 authors+ 7 authors

10 March 2015

We describe the multigram synthesis and in vivo efficacy studies of a donepezil‒huprine hybrid that has been found to display a promising in vitro multitarget profile of interest for the treatment of Alzheimer’s disease (AD). Its synthesis features...

(This article belongs to the Section Medicinal Chemistry)
  • Article
  • Open Access
4 Citations
4,743 Views
22 Pages

Noradrenaline Protects Human Microglial Cells (HMC3) Against Apoptosis and DNA Damage Induced by LPS and Aβ1-42 Aggregates In Vitro

  • Julia Barczuk,
  • Grzegorz Galita,
  • Natalia Siwecka,
  • Michał Golberg and ,
  • Kamil Saramowicz,
  • Zuzanna Granek,
  • Wojciech Wiese,
  • Ireneusz Majsterek and
  • Wioletta Rozpędek-Kamińska
  • + 4 authors+ 0 author

23 October 2024

Alzheimer’s disease (AD) is the most prevalent neurodegenerative disorder, characterized by the accumulation of amyloid-beta (Aβ) plaques and neuroinflammation. This study investigates the protective effects of noradrenaline (NA) on human...

(This article belongs to the Special Issue Neurodegenerative Diseases: Molecular Mechanisms and Therapies, 3rd Edition)
  • Article
  • Open Access
42 Citations
4,634 Views
13 Pages

21 August 2020

Amyloid beta (aβ) 1-42, a peptide that is 1-42 amino acids long, is a major component of senile plaques in the brains of patients with Alzheimer’s disease. Aβ detection has become an essential antecedence to predict the declining ment...

(This article belongs to the Section C: Chemistry)
  • Article
  • Open Access
28 Citations
5,746 Views
13 Pages

Ginsenoside F1 Protects the Brain against Amyloid Beta-Induced Toxicity by Regulating IDE and NEP

  • Yee-Jin Yun,
  • Bong-Hwan Park,
  • Jingang Hou,
  • Jung-Pyo Oh and ,
  • Jin-Hee Han and
  • Sun-Chang Kim
  • + 1 author+ 0 author

1 January 2022

Ginsenoside F1, the metabolite of Rg1, is one of the most important constituents of Panax ginseng. Although the effects of ginsenosides on amyloid beta (Aβ) aggregation in the brain are known, the role of ginsenoside F1 remains unclear. Here, we...

(This article belongs to the Section Pharmaceutical Science)
  • Article
  • Open Access
25 Citations
5,755 Views
12 Pages

22 November 2021

Alzheimer’s disease (AD) is a severe neurodegenerative disorder. AD is pathologically characterized by the formation of intracellular neurofibrillary tangles, and extracellular amyloid plaques which were comprised of amyloid-beta (Aβ) pept...

of 3